Literature DB >> 26676666

Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy.

Runa Lindblom1, Gavin Higgins1, Melinda Coughlan1, Judy B de Haan2.   

Abstract

Diabetic kidney disease is one of the major microvascular complications of both type 1 and type 2 diabetes mellitus. Approximately 30% of patients with diabetes experience renal complications. Current clinical therapies can only mitigate the symptoms and delay the progression to end-stage renal disease, but not prevent or reverse it. Oxidative stress is an important player in the pathogenesis of diabetic nephropathy. The activity of reactive oxygen and nitrogen species (ROS/NS), which are by-products of the diabetic milieu, has been found to correlate with pathological changes observed in the diabetic kidney. However, many clinical studies have failed to establish that antioxidant therapy is renoprotective. The discovery that increased ROS/NS activity is linked to mitochondrial dysfunction, endoplasmic reticulum stress, inflammation, cellular senescence, and cell death calls for a refined approach to antioxidant therapy. It is becoming clear that mitochondria play a key role in the generation of ROS/NS and their consequences on the cellular pathways involved in apoptotic cell death in the diabetic kidney. Oxidative stress has also been associated with necrosis via induction of mitochondrial permeability transition. This review highlights the importance of mitochondria in regulating redox balance, modulating cellular responses to oxidative stress, and influencing cell death pathways in diabetic kidney disease. ROS/NS-mediated cellular dysfunction corresponds with progressive disease in the diabetic kidney, and consequently represents an important clinical target. Based on this consideration, this review also examines current therapeutic interventions to prevent ROS/NS-derived injury in the diabetic kidney. These interventions, mainly aimed at reducing or preventing mitochondrial-generated oxidative stress, improving mitochondrial antioxidant defense, and maintaining mitochondrial integrity, may deliver alternative approaches to halt or prevent diabetic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26676666      PMCID: PMC5397988          DOI: 10.1900/RDS.2015.12.134

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  239 in total

1.  Identifying the components of the elusive mitochondrial permeability transition pore.

Authors:  Jason Karch; Jeffery D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

2.  Exposure to traffic exhausts and oxidative DNA damage.

Authors:  C-H Lai; S-H Liou; H-C Lin; T-S Shih; P-J Tsai; J-S Chen; T Yang; J J K Jaakkola; P T Strickland
Journal:  Occup Environ Med       Date:  2005-04       Impact factor: 4.402

3.  Urinary excretion of podocytes in patients with diabetic nephropathy.

Authors:  T Nakamura; C Ushiyama; S Suzuki; M Hara; N Shimada; I Ebihara; H Koide
Journal:  Nephrol Dial Transplant       Date:  2000-09       Impact factor: 5.992

4.  Peroxynitrite plays a key role in glomerular lesions in diabetic rats.

Authors:  Hui Xiao; Yanning Li; Jinsheng Qi; Hui Wang; Kun Liu
Journal:  J Nephrol       Date:  2009 Nov-Dec       Impact factor: 3.902

5.  XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response.

Authors:  Ann-Hwee Lee; Neal N Iwakoshi; Laurie H Glimcher
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

6.  Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production.

Authors:  Sergey I Dikalov; Anna E Dikalova; Alfiya T Bikineyeva; Harald H H W Schmidt; David G Harrison; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2008-08-16       Impact factor: 7.376

7.  Apoptosis in the kidneys of patients with type II diabetic nephropathy.

Authors:  D Verzola; M T Gandolfo; F Ferrario; M P Rastaldi; B Villaggio; F Gianiorio; M Giannoni; L Rimoldi; F Lauria; M Miji; G Deferrari; G Garibotto
Journal:  Kidney Int       Date:  2007-09-12       Impact factor: 10.612

8.  Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy.

Authors:  Masao Kanauchi; Hisayuki Nishioka; Toshio Hashimoto
Journal:  Nephron       Date:  2002-06       Impact factor: 2.847

Review 9.  DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis.

Authors:  Carol Bernstein; Harris Bernstein; Claire M Payne; Harinder Garewal
Journal:  Mutat Res       Date:  2002-06       Impact factor: 2.433

10.  Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy.

Authors:  Takeshi Nishikawa; Michael Brownlee; Eiichi Araki
Journal:  J Diabetes Investig       Date:  2014-07-25       Impact factor: 4.232

View more
  33 in total

Review 1.  The Role of Oxidative Stress and Bioenergetic Dysfunction in Sulfite Oxidase Deficiency: Insights from Animal Models.

Authors:  Angela T S Wyse; Mateus Grings; Moacir Wajner; Guilhian Leipnitz
Journal:  Neurotox Res       Date:  2018-12-05       Impact factor: 3.911

2.  Arginine 107 of yeast ATP synthase subunit g mediates sensitivity of the mitochondrial permeability transition to phenylglyoxal.

Authors:  Lishu Guo; Michela Carraro; Geppo Sartori; Giovanni Minervini; Ove Eriksson; Valeria Petronilli; Paolo Bernardi
Journal:  J Biol Chem       Date:  2018-08-09       Impact factor: 5.157

3.  Effects of Ganoderma Lucidum shell-broken spore on oxidative stress of the rabbit urinary bladder using an in vivo model of ischemia/reperfusion.

Authors:  Robert M Levin; Li Xia; Wu Wei; Catherine Schuler; Robert E Leggett; Alpha D-Y Lin
Journal:  Mol Cell Biochem       Date:  2017-05-08       Impact factor: 3.396

4.  HRD1-Mediated IGF-1R Ubiquitination Contributes to Renal Protection of Resveratrol in db/db Mice.

Authors:  Caifeng Yan; Weifeng Xu; Yujie Huang; Min Li; Yachen Shen; Hui You; Xiubin Liang
Journal:  Mol Endocrinol       Date:  2016-04-15

5.  Clavulanic Acid Attenuating Effect on the Diabetic Neuropathic Pain in Rats.

Authors:  Mahnoush Kolahdouz; Faranak Jafari; Farahnaz Falanji; Samad Nazemi; Mohammad Mohammadzadeh; Mehdi Molavi; Bahareh Amin
Journal:  Neurochem Res       Date:  2021-04-12       Impact factor: 3.996

Review 6.  Potential Biochemical Mechanisms of Lung Injury in Diabetes.

Authors:  Hong Zheng; Jinzi Wu; Zhen Jin; Liang-Jun Yan
Journal:  Aging Dis       Date:  2017-02-01       Impact factor: 6.745

7.  Calycosin-loaded nanoliposomes as potential nanoplatforms for treatment of diabetic nephropathy through regulation of mitochondrial respiratory function.

Authors:  Chunrong Huang; Lian-Fang Xue; Bo Hu; Huan-Huan Liu; Si-Bo Huang; Suliman Khan; Yu Meng
Journal:  J Nanobiotechnology       Date:  2021-06-13       Impact factor: 10.435

8.  Infiltrating macrophages in diabetic nephropathy promote podocytes apoptosis via TNF-α-ROS-p38MAPK pathway.

Authors:  Yinfeng Guo; Zhixia Song; Min Zhou; Ying Yang; Yu Zhao; Bicheng Liu; Xiaoliang Zhang
Journal:  Oncotarget       Date:  2017-06-07

Review 9.  Recent novel approaches to limit oxidative stress and inflammation in diabetic complications.

Authors:  Raelene J Pickering; Carlos J Rosado; Arpeeta Sharma; Shareefa Buksh; Mitchel Tate; Judy B de Haan
Journal:  Clin Transl Immunology       Date:  2018-04-18

Review 10.  Effects and Mechanisms of Taurine as a Therapeutic Agent.

Authors:  Stephen Schaffer; Ha Won Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.